MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Thursday, June 23, 2016

12:00pm-1:30pm
Syndrome of dystonia-parkinsonism is a complication of cyclosporine A treatment and may be irreversible

P. Miklavcic, S. Avcin, J. Jazbec, T. Vipotnik Vesnaver, B. Todorova, M. Trost, M. Kojovic (Ljubljana, Slovenia)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Synergistic effects of physical therapy and botulinum toxin in primary cervical dystonia

W. Hu, V. Rundle-Gonzalez, S.J. Kulkarni, L. Almeida, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Systematic literature review of quetiapine for hallucinosis / psychosis in Parkinson’s disease (PD)

K. Dashtipour, J.J. Chen, L. Massihi, S. Tashiro, K. Frei (Loma Linda, CA, USA)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Systems biological approach to Parkinson’s disease- Uncovering effects of PD on the synapse

K.F. Heil, O. Sorokina, J.D. Armstrong, J. Hellgren Kotaleski (Edinburgh, United Kingdom)

Other  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Taking specialist clinics into community nursing homes

T. Williams, S. Mahon, C. Thomas, B. Mohamed (Cardiff, United Kingdom)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Targeting PDE7 by the small molecule S14: A potential disease-modifying Parkinson�s disease therapy ready to start clinical trials

A. Martinez, C. Gil, D. Lopez Ribas, E. Cunchillos, J. Domenech, M. Sarasa (Madrid, Spain)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Tear fluid as potential biomarker for the diagnosis of Parkinson’s disease

M. Börger, S. Funke, F. Maaß, A. Fischbach, M. Bähr, F. Grus, P. Lingor (Göttingen, Germany)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Telemedicine facilitates efficient and safe home titration of levodopa/carbidopa intestinal gel (LCIG) in patients with advanced Parkinson’s disease

T. Willows, N. Dizdar, D. Nyholm, H. Widner, P. Grenholm, U. Schmiauke, A. Urbom, K. Groth, J. Larsson, J. Permert, S. Kjellander (Huddinge, Sweden)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Temporal discrimination threshold and the menstrual cycle

E.M. Mc Govern, E. O'Connor, I. Beiser, L. Williams, J.S. Butler, B. Quinlivan, R. Reilly, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Temporal dynamics of pallidal low-frequency oscillations in dystonia

D.A.I. Pina-Fuentes, J.C. van Zijl, J.W. Elting, G. Drost, J.M. van Dijk, M.A. Tijssen, M. Beudel (Groningen, Netherlands)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 53
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley